You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Humana Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Humana Company Info
The Company offers coordinated health insurance coverage and related services through a variety of traditional and consumer-choice plans for government-sponsored programs, employer groups, and individuals.
News & Analysis
An earnings beat and an encouraging piece of guidance didn't make the share price pop.
Healthcare is a durable economic sector.
One of these stocks hiked its dividend by as much as 50% in 2022.
This company is a major winner in the thriving health insurance industry.
Their yields aren't high, but these companies have been aggressively raising their dividend payments in recent years.
This leading health insurance company has created huge wealth for shareholders in recent years. But can it continue?
Whether your goal is building generational wealth or simply achieving financial independence, buying these two stocks could be worth your while.
Dividend growth streaks can be overrated.
From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last week's biggest healthcare stories.
HUM earnings call for the period ending September 30, 2021.
HUM earnings call for the period ending June 30, 2021.
HUM earnings call for the period ending March 31, 2021.
HUM earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.